Delivery Order SPE2DB24D1034-SPE2DB24FVYE2
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGEML product. The contract, valued at $1,408.95, has an ultimate completion date of March 25, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,352.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TWINRIX VACCINE SYRINGEML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $6,403.66 firm fixed-price delivery order contract for TWINRIX VACCINE SYRINGEML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB20D2002|SPE2DB24FL31A) worth $1,779.70 to provide the TWINRIX VACCINE SYRINGEML product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $231,266.24 firm fixed price delivery order contract to provide TWINRIX VACCINE SYRINGEML. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor and for-profit organization, to provide the TWINRIX VACCINE SYRINGE ML product. The $9,131.33 delivery order has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation and serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TWINRIX VACCINE SYRINGEML. The $11,112.95 contract has a performance period through January 29, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp has received numerous prior awards from DLA Troop Support Medical to supply pharmaceuticals, medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,705.52 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of TWINRIX VACCINE SYRINGEML, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $2,510.94, is for the delivery of TWINRIX VACCINE SYRINGEML to Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,348.52 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of TWINRIX VACCINE SYRINGEML, and has a period of performance through June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB24FVYE2Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,008.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the TWINRIX VACCINE SYRINGE ML product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation and is intended to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide through February 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 2/28/24 |